TSRC, Tob. Sci. Res. Conf., 2018, 72, abstr. 001 (Symposium)

Importance of science to FDA’s Center for Tobacco Products

HOLMAN M.R.
U.S. Food & Drug Administration, Silver Spring, MD, USA

As regulators of tobacco products, the U.S. FDA’s Center for Tobacco Products (CTP) is a science-based agency. Since its inception, CTP’s Office of Science (OS) has worked to build scientific knowledge around tobacco products in order to meet its public health mission. OS has not only increased the scientific knowledge of its staff but also puts considerable resources toward ensuring that all stakeholders have access to that knowledge. For example, OS staff co-author numerous publications in scientific journals each year. In addition, CTP funds research that is presented at scientific conferences and published in scientific journals regularly. CTP uses this ever-increasing scientific knowledge of tobacco products to make well-informed regulatory decisions founded in the best available science. The scientific basis for CTP’s decisions is evident in our actions (e.g., application review, rulemaking, guidance, and enforcement actions).